SCHEMBL6217231

SCHEMBL6217231

NC(=O)C1CCCC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19925753 0.86
SCHEMBL4022345 0.82
SCHEMBL931732 0.80
SCHEMBL13130776 0.80
SCHEMBL574892 0.80
Hydrochloric Acid SCHEMBL1703551 0.78 POLB (0.33)
SCHEMBL1703547 0.78
SCHEMBL6060229 0.74 SMN1; SMN2 (0.32)
SCHEMBL17675561 0.70 MAPK1 (0.34)
SCHEMBL8580876 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1176146-B1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO LTD (JP) 2005-06-08 EP claimed
CN-1174984-C Carbamoyl tetrahydropyridine derivatives ������ҩ��ʽ���� 2004-11-10 CN claimed
US-20030191122-A1 Carbamoyl tetrahydropyridine derivatives NAKAZATO ATSURO (JP) 2003-10-09 US claimed
US-6600038-B1 Intermediates for the preparation thereof are provided. The derivatives described above are effective for diseases which are believed to involve CRF. involving Corticotropin Releasing Factor (CRF), such as depression, anxiety, TAISHO PHARMACEUTICAL CO., LTD. (JP) 2003-07-29 US claimed
CN-1350536-A Carbamoyl tetrahydropyridine derivatives TAISHO PHARMACEUTICAL CO LTD (JP) 2002-05-22 CN claimed
EP-1176146-A1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD (JP) 2002-01-30 EP claimed
EP-2467398-B1 TRPC4 INHIBITORS AND USES THEREOF POSEIDA THERAPEUTICS INC (US) 2019-10-09 EP disclosed
EP-3194362-A1 METHOD FOR PRODUCING 1,5-PENTANEDIISOCYANATE IN THE GAS PHASE Covestro Deutschland AG (DE) 2017-07-26 EP disclosed
WO-2016042125-A1 METHOD FOR PRODUCING 1,5-PENTANEDIISOCYANATE IN THE GAS PHASE COVESTRO DEUTSCHLAND AG (DE) 2016-03-24 WO disclosed
US-20120148604-A1 TRP INHIBITORS AND USES THEREOF TRANSPOSAGEN BIOPHARMACEUTICALS, INC. (US) 2012-06-14 US disclosed
EP-1176146-B1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO LTD (JP) 2005-06-08 EP disclosed
EP-1176146-B1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO LTD (JP) 2005-06-08 EP disclosed
US-6894168-B2 Carbamoyl tetrahydropyridine derivatives TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-05-17 US disclosed
CN-1350536-A Carbamoyl tetrahydropyridine derivatives TAISHO PHARMACEUTICAL CO LTD (JP) 2002-05-22 CN disclosed
EP-1176146-A1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD (JP) 2002-01-30 EP disclosed
EP-1176146-A1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD (JP) 2002-01-30 EP disclosed
JP-2001151777-A DERIVATIVE OF CARBAMOYL TETRAHYDROPYRIDINE TAISHO PHARMACEUT CO LTD 2001-06-05 JP disclosed
WO-2000053604-A1 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2000-09-14 WO disclosed
US-5525600-A COMPOUND USEFUL AS ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANXIBLYTIC AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1996-06-11 US disclosed
US-4785009-A TETRAHYDROPYRIDINYL AMIDES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1988-11-15 US disclosed